Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Neoplasms, Nerve Sheath

imatinib mesylate has been researched along with Neoplasms, Nerve Sheath in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Armstrong, AE; Brossier, NM; Hirbe, AC1
Aoki, M; Hakozaki, M; Iwasaki, H; Nabeshima, K; Ogose, A; Ohishi, J; Suzumiya, J; Takeuchi, T; Yamashita, Y1
Afanasieva, A; Atallah, I; Estevez-Schwarz, L; Friedrich, RE; Hartmann, C; Holtkamp, N; Mautner, VF; Mawrin, C; Mucha, J; Okuducu, AF; von Deimling, A1
Aoki, M; Hamasaki, M; Iwasaki, H; Koga, K; Nabeshima, K; Suzumiya, J; Tamura, K1

Other Studies

4 other study(ies) available for imatinib mesylate and Neoplasms, Nerve Sheath

ArticleYear
Neurofibromatosis type 1-related tumours in paediatrics: an evolving treatment landscape.
    The Lancet. Child & adolescent health, 2020, Volume: 4, Issue:7

    Topics: Benzimidazoles; Child; Glioma; Humans; Imatinib Mesylate; Mitogen-Activated Protein Kinases; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Neurofibromin 1; Protein Kinase Inhibitors

2020
Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β.
    BMC cancer, 2013, May-04, Volume: 13

    Topics: Animals; Benzamides; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression; Gene Knockdown Techniques; Humans; Imatinib Mesylate; Mice; Mice, Inbred NOD; Mice, SCID; Mutation; Neoplastic Stem Cells; Nerve Sheath Neoplasms; Phosphorylation; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; RNA, Messenger

2013
Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity.
    Carcinogenesis, 2006, Volume: 27, Issue:3

    Topics: Antineoplastic Agents; Benzamides; Exons; Gene Amplification; Gene Expression Profiling; Humans; Imatinib Mesylate; Nerve Sheath Neoplasms; Piperazines; Polymorphism, Genetic; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Tumor Cells, Cultured

2006
Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB.
    Laboratory investigation; a journal of technical methods and pathology, 2007, Volume: 87, Issue:8

    Topics: Adult; Antineoplastic Agents; Becaplermin; Benzamides; Cell Line, Tumor; Female; Humans; Imatinib Mesylate; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Mutation; Neoplasm Invasiveness; Nerve Sheath Neoplasms; Phosphorylation; Piperazines; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Receptors, Growth Factor; RNA, Messenger

2007